Group financial statement for the first half of 2011 - Novozymes A/S

First half-year development in line with expectations. Full-year 2011 sales and earnings outlook maintained, free cash flow expectation increased Sales growth slowed somewhat after the strong first-quarter performance and is in line with expectations. The EBIT margin improved slightly despite the negative impact from acquisitions and unfavorable currency development. Free cash flow was very strong as a result of a stronger net profit and lower taxes paid compared to the same period last year. All expectations for full-year 2011 are maintained from previous guidance, except for free cash flow, which is increased.

August 11, 2011 02:06 ET  | Source: Novonesis (Novozymes A/S) Novonesis (Novozymes A/S)